Dow Jones

42,635.20

0.25%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

HUMA

Humacyte (HUMA)

Humacyte Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HUMA

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
06/01/2025	04:45	PR Newswire (US)	Humacyte, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - HUMA	NASDAQ:HUMA	Humacyte Inc
02/01/2025	10:40	PR Newswire (US)	The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) Shareholders	NASDAQ:HUMA	Humacyte Inc
02/01/2025	09:07	PR Newswire (US)	Humacyte, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HUMA	NASDAQ:HUMA	Humacyte Inc
30/12/2024	04:45	PR Newswire (US)	The Gross Law Firm Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA	NASDAQ:HUMA	Humacyte Inc
26/12/2024	04:45	PR Newswire (US)	Humacyte, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA	NASDAQ:HUMA	Humacyte Inc
23/12/2024	04:45	PR Newswire (US)	Investors in Humacyte, Inc. Should Contact The Gross Law Firm Before January 17, 2025 to Discuss Your Rights - HUMA	NASDAQ:HUMA	Humacyte Inc
12/12/2024	04:45	PR Newswire (US)	Class Action Filed Against Humacyte, Inc. (HUMA) - January 17, 2025 Deadline to Join - Contact The Gross Law Firm	NASDAQ:HUMA	Humacyte Inc
05/12/2024	04:45	PR Newswire (US)	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. Lawsuit - HUMA	NASDAQ:HUMA	Humacyte Inc
03/09/2024	15:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HUMA	Humacyte Inc
03/09/2024	15:11	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:HUMA	Humacyte Inc
29/08/2024	15:31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HUMA	Humacyte Inc
13/08/2024	15:47	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HUMA	Humacyte Inc
13/08/2024	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HUMA	Humacyte Inc
08/03/2024	15:03	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:HUMA	Humacyte Inc
29/02/2024	15:11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:HUMA	Humacyte Inc
11/09/2023	19:03	Dow Jones News	Stocks to Watch: Oracle, Acelyrin, Humacyte	NASDAQ:HUMA	Humacyte Inc
31/07/2023	12:28	Dow Jones News	Humacyte Shares Rise 8% After Completing Enrollment in Phase 2/3 Trial	NASDAQ:HUMA	Humacyte Inc
16/06/2023	15:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HUMA	Humacyte Inc
15/06/2023	15:25	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:HUMA	Humacyte Inc
09/06/2023	15:05	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:HUMA	Humacyte Inc
08/06/2023	15:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HUMA	Humacyte Inc
24/05/2023	15:53	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:HUMA	Humacyte Inc
12/05/2023	15:20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:HUMA	Humacyte Inc
28/04/2023	05:45	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:HUMA	Humacyte Inc
24/03/2023	07:51	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:HUMA	Humacyte Inc
10/11/2022	09:30	TipRanks	Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Humacyte (HUMA)	NASDAQ:HUMA	Humacyte Inc
19/09/2022	15:42	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:HUMA	Humacyte Inc
15/09/2022	05:33	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:HUMA	Humacyte Inc
12/09/2022	05:31	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:HUMA	Humacyte Inc
09/09/2022	15:44	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:HUMA	Humacyte Inc